These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20959811)

  • 1. Modifications of adenovirus hexon allow for either hepatocyte detargeting or targeting with potential evasion from Kupffer cells.
    Prill JM; Espenlaub S; Samen U; Engler T; Schmidt E; Vetrini F; Rosewell A; Grove N; Palmer D; Ng P; Kochanek S; Kreppel F
    Mol Ther; 2011 Jan; 19(1):83-92. PubMed ID: 20959811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus.
    Doronin K; Shashkova EV; May SM; Hofherr SE; Barry MA
    Hum Gene Ther; 2009 Sep; 20(9):975-88. PubMed ID: 19469693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer.
    Lucas T; Benihoud K; Vigant F; Schmidt CQ; Wortmann A; Bachem MG; Simmet T; Kochanek S
    PLoS One; 2015; 10(2):e0117254. PubMed ID: 25692292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer.
    Khare R; May SM; Vetrini F; Weaver EA; Palmer D; Rosewell A; Grove N; Ng P; Barry MA
    Mol Ther; 2011 Jul; 19(7):1254-62. PubMed ID: 21505422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity.
    Krutzke L; Prill JM; Engler T; Schmidt CQ; Xu Z; Byrnes AP; Simmet T; Kreppel F
    J Control Release; 2016 Aug; 235():379-392. PubMed ID: 27302248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.
    Short JJ; Rivera AA; Wu H; Walter MR; Yamamoto M; Mathis JM; Curiel DT
    Mol Cancer Ther; 2010 Sep; 9(9):2536-44. PubMed ID: 20736345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating antibodies and macrophages as modulators of adenovirus pharmacology.
    Khare R; Hillestad ML; Xu Z; Byrnes AP; Barry MA
    J Virol; 2013 Apr; 87(7):3678-86. PubMed ID: 23325678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors.
    Khare R; Reddy VS; Nemerow GR; Barry MA
    J Virol; 2012 Feb; 86(4):2293-301. PubMed ID: 22156515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting.
    Jönsson F; Hagedorn C; Kreppel F
    J Vis Exp; 2018 Oct; (140):. PubMed ID: 30417881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo.
    Zaiss AK; Foley EM; Lawrence R; Schneider LS; Hoveida H; Secrest P; Catapang AB; Yamaguchi Y; Alemany R; Shayakhmetov DM; Esko JD; Herschman HR
    J Virol; 2016 Jan; 90(1):412-20. PubMed ID: 26491162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropism.
    Alberti MO; Deshane JS; Chaplin DD; Pereboeva L; Curiel DT; Roth JC
    Gene Ther; 2013 Jul; 20(7):733-41. PubMed ID: 23171918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats.
    Nicol CG; Graham D; Miller WH; White SJ; Smith TA; Nicklin SA; Stevenson SC; Baker AH
    Mol Ther; 2004 Aug; 10(2):344-54. PubMed ID: 15294181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity.
    Shayakhmetov DM; Gaggar A; Ni S; Li ZY; Lieber A
    J Virol; 2005 Jun; 79(12):7478-91. PubMed ID: 15919903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined fiber modifications both to target α(v)β(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5.
    Coughlan L; Vallath S; Gros A; Giménez-Alejandre M; Van Rooijen N; Thomas GJ; Baker AH; Cascalló M; Alemany R; Hart IR
    Hum Gene Ther; 2012 Sep; 23(9):960-79. PubMed ID: 22708837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fiber shaft-chimeric adenovirus vectors lacking the KKTK motif efficiently infect liver cells in vivo.
    Di Paolo NC; Kalyuzhniy O; Shayakhmetov DM
    J Virol; 2007 Nov; 81(22):12249-59. PubMed ID: 17855526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
    Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E
    J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver.
    Vigant F; Descamps D; Jullienne B; Esselin S; Connault E; Opolon P; Tordjmann T; Vigne E; Perricaudet M; Benihoud K
    Mol Ther; 2008 Aug; 16(8):1474-80. PubMed ID: 18560416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber.
    Nakamura T; Sato K; Hamada H
    J Virol; 2003 Feb; 77(4):2512-21. PubMed ID: 12551989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexon-specific PEGylated adenovirus vectors utilizing avidin-biotin interaction.
    Suzuki-Kouyama E; Katayama K; Sakurai F; Yamaguchi T; Kurachi S; Kawabata K; Nakagawa S; Mizuguchi H
    Biomaterials; 2011 Feb; 32(6):1724-30. PubMed ID: 21106235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors.
    Shayakhmetov DM; Li ZY; Ni S; Lieber A
    J Virol; 2004 May; 78(10):5368-81. PubMed ID: 15113916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.